Revance Therapeutics
RVNC
₹312.01
Share price
0.00%
Change (1 day)
-17.75%
Change (1 year)
Categories
Revance Therapeutics (RVNC) - Total liabilities
Total liabilities on the balance sheet as of September 2024 : ₹53.39 Billion
According to Revance Therapeutics's latest financial reports the company's total liabilities are ₹53.39 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Revance Therapeutics - Total liabilities on balance sheet (from 2012 to 2024)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | ₹52.45 B | 11.34% |
| 2022-12-31 | ₹47.10 B | 36.79% |
| 2021-12-31 | ₹34.43 B | 36.13% |
| 2020-12-31 | ₹25.29 B | 209.04% |
| 2019-12-31 | ₹8.18 B | 45.03% |
| 2018-12-31 | ₹5.64 B | 229.2% |
| 2017-12-31 | ₹1.71 B | -7.54% |
| 2016-12-31 | ₹1.85 B | 23.64% |
| 2015-12-31 | ₹1.49 B | 46.99% |
| 2014-12-31 | ₹1.02 B | -90.83% |
| 2013-12-31 | ₹11.13 B | -11.66% |
| 2012-12-31 | ₹12.60 B | 21.9% |
| 2011-12-31 | ₹10.33 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 | ₹0.28 B | -99.46% | 🇺🇸 USA |
 | ₹9.284 T | 17,289.54% | 🇺🇸 USA |
 | ₹968.79 B | 1,714.51% | 🇺🇸 USA |